# Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

> **NCT02466711** · PHASE1 · COMPLETED · sponsor: **Motus Therapeutics, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Gastric Motility

## Interventions

- **DRUG:** Relamorelin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02466711
- **Lead sponsor:** Motus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02466711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02466711, "Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02466711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*